Efficacy and Safety of Botulinum Toxin vs. Placebo in Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Botulinum Toxin vs. Placebo in Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background: Major depressive disorder (MDD) is a serious mental disorder that represents a substantial public health problem. Several trials have been undertaken to investigate the role of botulinum toxin type A (BTX-A) in the treatment of MDD, but the conclusions were controversial. To examine the...

Full description

Bibliographic Details
Main Authors: Huan Qian, Fangjie Shao, Cameron Lenahan, Anwen Shao, Yingjun Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Psychiatry
Subjects:
botulinum toxin type A
antidepressant
depression
systematic review
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2020.603087/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2020.603087/full

Similar Items